Intravitreal aflibercept for neovascular AMD in the very elderly neovascular AMD patients: UK Multi-centre Real World Outcome

被引:0
|
作者
Talks, James [1 ]
Sivaprasad, Sobha [2 ]
机构
[1] Newcastle Upon Tyne Hosp NHS Fdn Trust, Ctr Eye, Newcastle Upon Tyne, Tyne & Wear, England
[2] Moorfields Eye Hosp, London, England
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
911
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Intravitreal Aflibercept for Recalcitrant Neovascular AMD
    Maldonado, Maria
    Brown, David
    Wyko, Charles
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [2] Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD
    Avery, Robert L.
    Castellarin, Alessandro A.
    Steinle, Nathan C.
    Dhoot, Dilsher S.
    Pieramici, Dante Joseph
    See, Robert
    Couvillion, Stephen
    Nasir, Ma'an A.
    Rabena, Melvin D.
    Le, Kha
    Maia, Mauricio
    Visich, Jennifer E.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2014, 98 (12) : 1636 - 1641
  • [3] Trends in Real-World Neovascular AMD Treatment Outcomes in the UK
    Mehta, Hemal
    Kim, Leah N.
    Mathis, Thibaud
    Zalmay, Pardis
    Ghanchi, Faruque
    Amoaku, Winfried M.
    Kodjikian, Laurent
    [J]. CLINICAL OPHTHALMOLOGY, 2020, 14 : 3331 - 3342
  • [4] Intravitreal Aflibercept in Eyes with Neovascular AMD Requiring Frequent Retreatment with Intravitreal Bevacizumab or Ranibizumab
    Thorell, Mariana Rossi
    Nunes, Renata Portella
    Gregori, Giovanni
    Feuer, William J.
    Rosenfeld, Philip J.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [5] Verteporfin therapy with intravitreal triamcinolone in patients with neovascular AMD
    Moshfeghi, AA
    Puliafito, CA
    Rosenfeld, PJ
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U76 - U76
  • [6] Real-world analysis of brolucizumab in neovascular AMD
    Rave, Vanessa
    Sharma, Kayshaliya
    Wagner, Alan
    Kapoor, Kapil
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [7] Genetic Association with Response to Intravitreal Ranibizumab in Patients with Neovascular AMD
    Kloeckener-Gruissem, Barbara
    Barthelmes, Daniel
    Labs, Stephan
    Schindler, Christian
    Kurz-Levin, Malaika
    Michels, Stephan
    Fleischhauer, Johannes
    Berger, Wolfgang
    Sutter, Florian
    Menghini, Moreno
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (07) : 4694 - 4702
  • [8] Choroidal Thickness Changes After Intravitreal Aflibercept Injections in Treatment-Naive Neovascular AMD
    Minnella, Angelo Maria
    Centini, Chiara
    Gambini, Gloria
    Savastano, Maria Cristina
    Pagliei, Valeria
    Falsini, Benedetto
    Rizzo, Stanislao
    Ciasca, Gabriele
    Maceroni, Martina
    [J]. ADVANCES IN THERAPY, 2022, 39 (07) : 3248 - 3261
  • [9] Intravitreal Aflibercept for Neovascular AMD: Short-Term Clinical Effects of Intravitreal Aflibercept Injection as a Predictor of Long-Term Results
    Liu, Enchun M.
    Shah, Gaurav
    Blinder, Kevin J.
    Smith, Bradley T.
    Thomas, Matthew A.
    [J]. OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2015, 46 (10): : 1021 - 1027
  • [10] Real World Vienna: The VIBES Study - Outcomes and procedures in neovascular AMD
    Gerendas, Bianca S.
    Sadeghipour, Amir
    Buehl, Wolf
    Sacu, Stefan
    Schmidt-Erfurth, Ursula
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)